Patents by Inventor Yongzhen Li

Yongzhen Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240067546
    Abstract: A device and method for enhancing nitrogen and phosphorus removal based on a multistage AO partial denitrification coupled with Anammox process in combination with a sludge hydrolytic acidification mixture belong to the technical field of active sludge method wastewater treatment. A system includes a water tank, a water pump, a biochemical reaction zone, a hydrolytic acidification tank and other devices.
    Type: Application
    Filed: July 21, 2021
    Publication date: February 29, 2024
    Inventors: Yongzhen Peng, Qi Zhao, Ruitao Gao, Jianwei Li, Liyan Deng
  • Patent number: 11661467
    Abstract: The present disclosure discloses a high-performance rubber damping material and a method for preparing the same, relating to the technical field of damping materials. The method for preparing the high-performance rubber damping material includes: grafting hydroxyethyl methacrylate and lignin to a rubber molecular chain of natural rubber latex through graft copolymerization reaction, so as to obtain a high-performance rubber damping material. This method adopts natural rubber latex as a base material, the hydroxyethyl methacrylate and lignin are grafted to the rubber molecular chain of natural rubber latex through graft copolymerization reaction, to form a semi-interpenetrating network structure.
    Type: Grant
    Filed: March 26, 2021
    Date of Patent: May 30, 2023
    Assignee: Agricultural Products Processing Research Inst., Chinese Academy of Tropical Agricultural Sciences
    Inventors: Hongchao Liu, Heping Yu, Qifang Wang, Yongzhen Li, Zheng Peng
  • Publication number: 20220402918
    Abstract: The disclosure relates to an indolo[2?,3?:3,4]pyrido[2,1-b]quinazoline compound represented by general formula (I) and use thereof in the manufacture of (1) a medicament for treating a cardiovascular and cerebrovascular disease, (2) a formulation for increasing expression of AMPK, ABCA1 and SR-BI, (3) a formulation for activating nuclear receptors (NRs), and inhibiting activity of NLRP3, IL-1?, NF-?B and MAPKs, (4) a formulation for promoting cellular cholesterol efflux; or (5) a medicament for anti-inflammation.
    Type: Application
    Filed: September 27, 2020
    Publication date: December 22, 2022
    Inventors: Shuyi SI, Yanni XU, Xiao WANG, Jinque LUO, Yongzhen LI, Chao LIU, Xinhai JIANG, Yining LI, Xiaowan HAN, Yan LI, Minghua CHEN, Jing ZHANG, Xin ZHEN
  • Publication number: 20210395423
    Abstract: The present disclosure discloses a high-performance rubber damping material and a method for preparing the same, relating to the technical field of damping materials. The method for preparing the high-performance rubber damping material includes: grafting hydroxyethyl methacrylate and lignin to a rubber molecular chain of natural rubber latex through graft copolymerization reaction, so as to obtain a high-performance rubber damping material. This method adopts natural rubber latex as a base material, the hydroxyethyl methacrylate and lignin are grafted to the rubber molecular chain of natural rubber latex through graft copolymerization reaction, to form a semi-interpenetrating network structure.
    Type: Application
    Filed: March 26, 2021
    Publication date: December 23, 2021
    Inventors: Hongchao LIU, Heping YU, Qifang WANG, Yongzhen LI, Zheng PENG
  • Patent number: 11175289
    Abstract: A TRPM8 related peptide fragment, comprising amino acid sequence as shown in SEQ ID No: 1-18 is provided. Furthermore, application of TRPM8 protein, TRPM8 related peptide fragment and their antibodies in preparing diagnostic reagent for chronic prostatitis/chronic pelvic pain syndromes (CP/CPPS) is provided. By detecting level of TRPM8 protein molecule, TRPM8 related peptide fragment and their antibodies, the chronic prostatitis/chronic pelvic pain syndromes (CP/CPPS) is effectively diagnosed, and the present invention is capable of effectively making a distinction between CP/CPPS and other diseases of prostate.
    Type: Grant
    Filed: November 16, 2016
    Date of Patent: November 16, 2021
    Inventors: Lei Han, Xiaohui Zhou, Yuyan Zhou, Li Zhou, Guohua Li, Yongzhen Li
  • Publication number: 20170219603
    Abstract: A TRPM8 related peptide fragment, comprising amino acid sequence as shown in SEQ ID No: 1-18 is provided. Furthermore, application of TRPM8 protein, TRPM8 related peptide fragment and their antibodies in preparing diagnostic reagent for chronic prostatitis/chronic pelvic pain syndromes (CP/CPPS) is provided. By detecting level of TRPM8 protein molecule, TRPM8 related peptide fragment and their antibodies, the chronic prostatitis/chronic pelvic pain syndromes (CP/CPPS) is effectively diagnosed, and the present invention is capable of effectively making a distinction between CP/CPPS and other diseases of prostate.
    Type: Application
    Filed: November 16, 2016
    Publication date: August 3, 2017
    Inventors: Lei Han, Xiaohui Zhou, Yuyan Zhou, Li Zhou, Guohua Li, Yongzhen Li
  • Patent number: 8980887
    Abstract: Disclosed are 2-arylimidazo[1,2-a]pyridine-3-acetamide derivatives represented by formula I, their tautomer, racemate or optical isomer, their pharmaceutically acceptable salt, or their solvates, wherein R1, R2, R3 and R4 are defined as in the specification.
    Type: Grant
    Filed: June 9, 2011
    Date of Patent: March 17, 2015
    Assignees: Institute of Pharmacology, Toxicology Academy of Military Medical Sciences P.L.A., China
    Inventors: Rifang Yang, Yunfeng Li, Yongzhen Li, Nan Zhao, Liuhong Yun, Juanjuan Qin, Zhongyao Feng, Youzhi Zhang
  • Patent number: 8921563
    Abstract: Provided are N-[(4-hydroxypiperidin-4-yl)methyl]pyridin-2(1H)-one derivatives represented by formula I, stereoisomers, pharmaceutically acceptable salts or solvates thereof. The above compounds have the dual activities of 5-hydroxytryptamine 1A receptor ligand and selective serotonin reuptake inhibitor. The preparation methods of the above compounds, the uses of these compounds for the prevention or treatment of nervous system diseases related to 5-hydroxytryptamine system dysfunction and the pharmaceutical compositions containing these compounds are also provided.
    Type: Grant
    Filed: April 8, 2011
    Date of Patent: December 30, 2014
    Assignee: Institue of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A., China
    Inventors: Yunfeng Li, Rifang Yang, Youzhi Zhang, Yongzhen Li, Zengliang Jin, Peng Li, Li Yuan, Liuhong Yun, Nan Zhao, Cheng Zhang, Xiaodan Xu, Rusheng Zhao, Hongxia Chen, Rui Xue, Juanjuan Qin, Zhenzhen Wang, Jiazhi Yao
  • Publication number: 20130231369
    Abstract: Provided are N-[(4-hydroxypiperidin-4-yl)methyl]pyridin-2(1H)-one derivatives represented by formula I, stereoisomers, pharmaceutically acceptable salts or solvates thereof. The above compounds have the dual activities of 5-hydroxytryptamine 1A receptor ligand and selective serotonin reuptake inhibitor. The preparation methods of the above compounds, the uses of these compounds for the prevention or treatment of nervous system diseases related to 5-hydroxytryptamine system dysfunction and the pharmaceutical compositions containing these compounds are also provided.
    Type: Application
    Filed: April 8, 2011
    Publication date: September 5, 2013
    Applicant: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
    Inventors: Yunfeng Li, Rifang Yang, Youzhi Zhang, Yongzhen Li, Zengliang Jin, Peng Li, Li Yuan, Liuhong Yun, Nan Zhao, Cheng Zhang, Xiaodan Xu, Rusheng Zhao, Hongxia Chen, Rui Xue, Juanjuan Qin, Zhenzhen Wang, Jiazhi Yao
  • Publication number: 20130203754
    Abstract: Disclosed are 2-arylimidazo[1,2-a]pyridine-3-acetamide derivatives represented by formula I, their tautomer, racemate or optical isomer, their pharmaceutically acceptable salt, or their solvates, wherein R1, R2, R3 and R4 are defined as in the specification.
    Type: Application
    Filed: June 9, 2011
    Publication date: August 8, 2013
    Applicant: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
    Inventors: Rifang Yang, Yunfeng Li, Yongzhen Li, Nan Zhao, Liuhong Yun, Juanjuan Qin, Zhongyao Feng, Youzhi Zhang